Epclusa
50 mg + 200 mg · Pellet
- Prescription only
- Hepatitis C Virus NS5A Inhibitor
- Active substance
- Velpatasvir and Sofosbuvir
- Made by
- Gilead Sciences, Inc.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
France1 matching products
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Gilead Sciences, Inc. |
|---|---|
| Active substance | Velpatasvir and Sofosbuvir |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Strength | 50 mg + 200 mg |
| Form | Pellet |
| Route | Oral |
| Packs | 28 PACKET in 1 CARTON / 1 PELLET in 1 PACKET |
| NDC | 61958-2204 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Pellet2 products
- 37.5 mg + 150 mg
- 50 mg + 200 mg
- Tablet, Film Coated2 products
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.